0001209191-19-019399.txt : 20190314
0001209191-19-019399.hdr.sgml : 20190314
20190314160622
ACCESSION NUMBER: 0001209191-19-019399
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190312
FILED AS OF DATE: 20190314
DATE AS OF CHANGE: 20190314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cole G Bradley
CENTRAL INDEX KEY: 0001337798
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 19681108
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-12
0
0001131324
GENOMIC HEALTH INC
GHDX
0001337798
Cole G Bradley
301 PENOBSCOT DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
CFO
Common Stock
2019-03-12
4
M
0
5000
17.18
A
48722
I
Held by the Cole Family Trust
Common Stock
2019-03-12
4
M
0
10000
22.98
A
58722
I
Held by the Cole Family Trust
Common Stock
2019-03-12
4
S
0
4000
74.984
D
54722
I
Held by the Cole Family Trust
Common Stock
2019-03-12
4
S
0
1000
75.805
D
53722
I
Held by the Cole Family Trust
Common Stock
2019-03-12
4
S
0
7900
74.9768
D
45822
I
Held by the Cole Family Trust
Common Stock
2019-03-12
4
S
0
2100
75.8167
D
43722
I
Held by the Cole Family Trust
Employee Stock Option (right to buy)
17.18
2019-03-12
4
M
0
5000
0.00
D
2020-02-18
Common Stock
5000
21471
D
Employee Stock Option (right to buy)
22.98
2019-03-12
4
M
0
10000
0.00
D
2021-01-27
Common Stock
10000
16424
D
Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 4, 2018.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $74.53 to $75.42.
Represents weighted average sale price. Actual sale prices ranged from $75.64 to $75.96.
These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 23, 2018.
Represents weighted average sale price. Actual sale prices ranged from $74.52 to $75.44.
Represents weighted average sale price. Actual sale prices ranged from $75.66 to $76.04.
The option became exercisable as to 25% of the shares on February 18, 2011, and became exercisable as to 1/48th of the shares each full month thereafter.
The option became exercisable as to 25% of the shares on January 27, 2012, and became exercisable as to 1/48th of the shares each full month thereafter.
/s/ Jason W. Radford, Attorney-in-fact
2019-03-14